Sees FY25 adjusted EBITDA $144M-$154M. The company continues to experience strong customer retention and late-stage pipeline activity.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EVH:
- Evolent Health reports Q3 adjusted EPS 5c, consensus 10c
- Evolent Health’s Strategic Exit and Profitability Boost Underpin Buy Rating
- Micron reports Q4 beat, Instagram reports 3B MAUs: Morning Buzz
- Closing Bell Movers: Micron up marginally after initial post-earnings spike
- Evolent Health Divests Primary Care Business to Privia